1. Introduction {#s0005}
===============

Social anxiety disorder (SAD) is a common, disabling, and costly mental illness in the U.S. ([@bb0005], [@bb0010], [@bb0015]). The disorder is highly comorbid with major depressive disorder, other anxiety disorders ([@bb0020]), and is associated with functional impairment in major life domains ([@bb0005], [@bb0025]). Adding burden to the individual and society, the course of SAD tends to be protracted unless effectively treated ([@bb0030]). Cognitive Behavioral Therapy (CBT) is empirically-supported psychotherapy for SAD and other internalizing conditions ([@bb0035], [@bb0040]). In CBT patients are taught adaptive ways to manage negative events; therefore, improvement in regulating emotions is a treatment target ([@bb0045]). Though CBT is broadly efficacious, clinical outcome varies considerably, for example, in real-world settings recovery following CBT ranges from 14% to 48% ([@bb0050]).

Identifying which patient is likely to benefit from treatment has been an intensive area of research as it has the potential to contribute to precision medicine by guiding treatment selection and developing novel interventions. Accruing data indicate brain-based predictors are frequently better in foretelling who is likely to improve following CBT relative to demographic or baseline clinical information alone ([@bb0055], [@bb0060], [@bb0065], [@bb0070]). These reports suggest that baseline variance in brain activity interacts with CBT. Less clear is the extent to which a neuromarker is both prognostic of clinical outcome and relevant to the active components of CBT.

More specifically, the majority of research in neuromarkers over the past decade has been in patients with depression treated with pharmacotherapy and to a lesser extent CBT ([@bb0075], [@bb0080], [@bb0085], [@bb0090], [@bb0095], [@bb0100], [@bb0105], [@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130], [@bb0135], [@bb0140], [@bb0145]). Neuroimaging studies with fMRI or PET that have identified neuromarkers predominately involved simple, affective tasks (e.g., viewing negative words or images) ([@bb0085], [@bb0090], [@bb0095], [@bb0100]); (though see Carl and colleagues ([@bb0105]) concerning reward processing), or resting state ([@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130], [@bb0135], [@bb0140], [@bb0145]), a probe of self-referential processes ([@bb0150], [@bb0155], [@bb0160], [@bb0165]). Across these studies, treatment response has generally been predicted by baseline rostral anterior cingulate cortex (ACC) activity ([@bb0085], [@bb0090], [@bb0100], [@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130], [@bb0135], [@bb0140], [@bb0145]); however, joint rostral and dorsal ACC ([@bb0105], [@bb0145]) and activity in dorsal ACC singly ([@bb0095]) have also functioned as neuromarkers. Collectively, the ACC, particularly rostral ACC, appears to be a reproducible predictor of treatment outcome in depression, which shares neurobiological features with SAD ([@bb0170]). Yet, little is known about rostral or dorsal ACC (rACC, dACC) regions predicting CBT outcome as it relates to tasks that probe emotion regulation even though skills practiced in CBT are intended to enhance regulation ([@bb0035], [@bb0040]).

Regulation includes reappraisal, a cognitive approach (e.g., re-framing stimulus content) intended to dampen or alter the trajectory of an emotional response to a negative event ([@bb0175]). Evidence of emotion dysregulation in SAD are positive associations between SAD and maladaptive regulation strategies along with low confidence when implementing reappraisal in daily life ([@bb0180]). Cognitive interventions in CBT encompass strategies akin to reappraisal (e.g., cognitive restructuring) ([@bb0045]) and reappraisal is utilized more frequently in SAD patients who participated in CBT ([@bb0185]). Thus, reappraisal, an adaptive explicit form of regulation ([@bb0175]), is a proxy to techniques practiced in CBT. In contrast to an explicit approach, implicit emotion regulation is automatic in nature and encompasses attentional control, for example, the ability to effectively execute goal-directed behavior in the face of salient, sensory-driven distractors. SAD is associated with deficient attentional control as evinced by recurrent reports of attentional bias to threat-relevant stimuli ([@bb0190]). Although CBT does not directly focus on remediating attentional bias to threat per se, clinical improvement in SAD is associated with increased attentional control ([@bb0195], [@bb0200], [@bb0205]) suggesting implicit regulation is benefited by CBT techniques.

Brain regions that underlie emotion regulation include the ACC, which is part of a cortico-limbic system and serves as central hub for cognitive and emotional networks. Broadly, the affective, rACC is implicated in implicit regulation ([@bb0210], [@bb0215], [@bb0220]) and evaluative functions (e.g., assessing salience of stimuli) ([@bb0225], [@bb0230]). The rACC has interconnections with the amygdala, a key region in detecting salient stimuli and generating emotional reactions ([@bb0235], [@bb0240], [@bb0245], [@bb0250], [@bb0255]). The rACC also receives input from the dorsal 'cognitive' division of the ACC. Relative to rACC, the dorsal ACC (dACC) is more closely involved with conflict-related processes (e.g., conflict monitoring, error detection) and adaptive response to motivationally-relevant information ([@bb0225], [@bb0230], [@bb0260], [@bb0265], [@bb0270], [@bb0275], [@bb0280]).

Indices of successful reappraisal include self-reported reduction in negative affective state and a negative relationship between frontal regions and amygdala reactivity ([@bb0285], [@bb0290], [@bb0295], [@bb0300]). The dACC may be especially pertinent in reappraisal as indicated by meta-analytic studies showing its recruitment in healthy individuals along with reduced amygdala reactivity ([@bb0305], [@bb0310]). In SAD, delayed dACC engagement, among other frontal regions, has been observed when reappraising negative beliefs compared to controls ([@bb0315]). Findings further support the role dACC plays in reappraisal in addition to evidence of emotion dysregulation in SAD.

Conversely, rACC engagement is frequently demonstrated during attentional control in the context of salient distractors, attesting to its function in effectively managing competing streams of information ([@bb0225], [@bb0230], [@bb0320], [@bb0325]). In keeping with a top-down model of effective regulation, rACC activity in implicit regulation has been shown to reduce amygdala reactivity ([@bb0215]). In SAD, there are reports of reduced rACC activation, relative to healthy participants, in the face of emotional distractors ([@bb0330], [@bb0335]) suggesting attentional bias to salient distractors is due in part to deficient rACC activity, a key region in resolving such emotional interference ([@bb0230], [@bb0320]).

Altogether, successful regulation is indicated by an inverse relationship between dACC or rACC engagement and amygdala activity ([@bb0285], [@bb0290], [@bb0295], [@bb0300]). Accordingly, demonstrations of delayed or hypoactive ACC activity in SAD suggest inefficient or diminished regulation facility.

With regard to ACC as a predictor of CBT response in SAD, a machine-learning approach by Månsson and colleagues ([@bb0340]) revealed dACC-related information to negative stimuli in SAD was highly predictive in classifying CBT responders a year after completing treatment whereas limbic/paralimbic (amygdala, hippocampus, insula) and prefrontal regions (dorsolateral prefrontal cortex \[DLPFC\], ventromedial prefrontal cortex \[VMPFC\]) were less predictive. In further support, our correlational findings based on conventional whole-brain thresholds revealed pre-CBT rACC and dACC response to emotional stimuli, or during resting-state, corresponded with decreases in social anxiety symptoms (Δ~PreTx\ -\ PostTx~) ([@bb0335], [@bb0345]). Concerning implicit regulation, we observed clinical improvement was predicted by less dACC-DLPFC functional coupling, along with insula engagement, to threat distractors. Findings suggest that less baseline regulation capability at the neural level was prognostic of better CBT outcome ([@bb0350]).

For explicit emotion regulation, limited research in SAD has failed to show a link between ACC activity and CBT outcome thus far. Specifically, when using cognitive reappraisal to reduce negative affective state that would otherwise result from viewing negative stimuli, pre-to-post CBT alterations in prefrontal activity, posterior superior temporal gyrus, and middle occipital gyrus significantly accounted for the reduction in social anxiety symptoms ([@bb0355]). However, it is possible that brain regions related to neurofunctional change over the course of CBT may not serve as neuromarkers. In a separate study, we explored baseline neural predictors using a conservative threshold (i.e., correction for multiple comparisons) and whole-brain findings demonstrated clinical improvement following CBT was predicted by less reappraisal-related activity in the DLPFC but not ACC ([@bb0060]).

Although a conservative approach may have reduced our ability to detect ACC effects, results are in line with implicit regulation findings as patients with deficient regulation prior to starting CBT benefited more from treatment. Nonetheless, the issue of what constitutes significant neural activity is important as determination of significance in fMRI research is on-going ([@bb0360], [@bb0365]) and in lieu of a gold standard criterion, attempts to protect against Type I error may be overly conservative ([@bb0370]). Consequently, reliance on stringent criteria may impede the detection of reproducible neuromarkers, particularly when shifting from the discovery phase to the generalization phase of neural treatment predictors ([@bb0375]). In other words, a neuromarker may be statistically robust yet not stable or generalizable, which are essential biomarker characteristics. Alternatively, a neuromarker may be significant and meaningful, but given cost constraints and resulting low power, not survive correction and result in Type II error.

In general, 'CBT neuromarker' studies of SAD indicate baseline activation in frontal regions (e.g., ACC) and/or subcortical regions (e.g., amygdala) during emotion processing, emotion regulation, or resting state predict symptom improvement ([@bb0060], [@bb0070], [@bb0340], [@bb0350], [@bb0355], [@bb0380], [@bb0385]). However, results have been inconsistent, which may relate to methodological differences across studies. That is, the direction of neuromarker effects (enhanced vs. reduced activation) is sensitive to the neurocognitive probe of interest (e.g., type of task), location within a region (e.g., dorsal versus rostral ACC) ([@bb0390]), and criteria used to define 'significance' of brain activity as noted above.

In the current study, we extend the literature by drawing on our previous investigations, which revealed implicit regulation-related dACC activity predicted CBT outcome ([@bb0350]) whereas explicit regulation failed to yield an ACC neuromarker ([@bb0060]). Notably, in contrast to these studies, hypotheses were tested with anatomy-based masks independent of a brain map. By taking a completely a priori approach, significant results would strengthen the proposal that the ACC is a promising marker of CBT response in SAD and contribute to methodological considerations when testing theoretically-relevant, propitious treatment predictors. Anatomical based, a priori prediction is a more stringent test of the hypothesis, as anatomical boundaries will be less specific than neurofunctional boundaries, including many likely null voxels along with the key voxels of interest.

Based on literature and theory, we hypothesized ACC activity, but not clinical or demographic data, would significantly portend CBT 'responders' as a neuromarker. We also expected greater baseline rACC activity during implicit regulation would foretell clinical improvement. We hypothesized dACC in explicit regulation would predict responder status, however, no supposition was made as to the direction of activation (i.e., less or more) due to lack of data in the literature. Given strong anatomical connections between the ACC and amygdala ([@bb0395]), the predictive validity of amygdala was explored in addition to ACC-amygdala relationships as an index of emotion regulation success before starting CBT. In accordance with a top-down framework of regulation ([@bb0285], [@bb0290], [@bb0295], [@bb0300]) and evidence of inefficient or impoverished ACC recruitment during explicit or implicit regulation in SAD ([@bb0315], [@bb0330], [@bb0335]), a positive ACC-amygdala association would suggest deficient regulation and an inverse relationship, effective emotion regulation. A secondary aim was to evaluate relationships between pre-to-post change in symptom severity and ACC and amygdala activity.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

All participants provided written informed consent as approved by the local Institutional Review Board at the University of Illinois at Chicago (UIC); 50% of participants were reported in a previous implicit regulation study ([@bb0350]) and 76% were reported in an explicit regulation study ([@bb0060]). Treatment-seeking patients with generalized SAD were recruited through the Mood and Anxiety Disorders Program at UIC by means of flyers posted throughout the communities, newspaper, and internet advertisement. Interested participants completed a phone screen followed by a psychiatric evaluation during which time participants reviewed the consent form. After attaining consent, participants met with a clinician trained in the Structured Clinical Interview for DSM-IV (SCID-IV; ([@bb0400])) and clinician-administered measures. The participant\'s medical history was reviewed by a Board Certified physician and during the evaluation participants completed self-report measures.

Diagnosis was based on the SCID-IV and the clinician-administered Liebowitz Social Anxiety Scale (LSAS; ([@bb0405])) was used to assess symptom severity. Depression level was examined with the clinician-administered Hamilton Depression Rating Scale (HAM-D; ([@bb0410])). A non-treating clinician administered the LSAS and HAM-D before and immediately after CBT was completed. Self-reported attentional control was evaluated with the Attentional Control Scale where higher scores signify more control (ACS; ([@bb0415])). Subjective emotion regulation was assessed with the Emotion Regulation Questionnaire (ERQ; ([@bb0175])). Higher scores indicate greater habitual use of reappraisal and expressive suppression ([@bb0175]). Treating clinicians completed the Clinical Global Impression Rating Scale (CGI; ([@bb0420])) which encompasses the Clinical Improvement Scale (CGI-I) measuring global improvement with scores ranging from 1 (very much improved) through 7 (very much worse).

All measures were collected within a week of study entry and baseline fMRI scan. Participants were required to test negative on a urine toxicology screen before the scan. All participants were compensated for their time and all procedures complied with the Helsinki Declaration.

2.2. Inclusion/exclusion criteria {#s0020}
---------------------------------

Participants were between 18 and 65 years of age, free of major medical or neurologic illness as confirmed by a Board Certified physician. All but two participants were free of psychotropic medications (i.e., sertraline) and none were receiving concurrent psychotherapy.

Exclusion criteria included contraindications to magnetic resonance imaging (e.g., pregnancy, non-removable ferrous objects), current substance dependence (within 6 months of study), history of other major psychiatric illness (e.g., bipolar disorder, psychotic disorders), or current cognitive dysfunction (e.g., traumatic brain injury, pervasive developmental disorder, dementia).

2.3. Treatment {#s0025}
--------------

Within a week of the fMRI scan, patients began once-weekly sessions of manualized individual CBT for 12 weeks, which included psycho-education, cognitive techniques to reduce negative beliefs (e.g., cognitive restructuring), in vivo exposure to fears, and relapse prevention ([@bb0425]). A CBT-trained licensed clinical psychologist or post-doctoral clinical psychologist conducted treatment. The clinicians were supervised by a licensed clinical psychologist with expertise in CBT and clinical trials.

Patients were considered to be 'Responders' if their CGI score was 1 or 2 and if they met the criterion value based on a reliable change index (RCI) ([@bb0430]). The LSAS total score was used to calculate the RCI where an absolute value \> 1.96 indicates change is statistically significant ([@bb0435]).

2.4. fMRI tasks {#s0030}
---------------

The order of implicit and explicit emotion regulation tasks were counterbalanced across participants. In the Emotional Faces Interference Task (EFIT), participants viewed a string of six letters superimposed on a task-irrelevant face distractor and instructed to identify target letters (N or X). In low perceptual load trials, the string was comprised entirely of target letters whereas under high perceptual load, the string included a single target letter and five non-target letters (H, K, M, W, Z) in randomized order. Distractor faces were from a standardized set of photographs and consisted of fearful, angry, and neutral expressions from 8 different individuals ([@bb0440]). The experiment involved two image acquisition runs, each comprising 12 blocks of 5 trials. A mixed block/event-related design was employed whereby perceptual load (low vs. high) varied across blocks and facial expression (fearful, angry, neutral) varied within blocks on a trial-by-trial basis. Images were presented for 200 ms followed by a fixation cross presented for 1800 ms; responses were made via button press. Within blocks, trials were separated by a jittered inter-stimulus interval lasting 2--6 s; trials between blocks were separated by 4--8 s.

The Emotion Regulation Task (ERT) comprised 64 unpleasant and 32 neutral International Affective Picture System images ([@bb0445]). Eight 20-s blocks of each condition (four images presented for 5 s each) were interspersed with 20-s baseline blocks (comprising a fixation cross). At the beginning of each block, participants were instructed to: 1) use a cognitive strategy to reduce negative affect evoked by an aversive image ("Reappraise"); 2) attend to, be aware of, and "feel what you naturally feel" when looking at an aversive image ("Maintain"); or 3) view neutral images ("Look"). Immediately following each task block, participants were asked to rate "How negative do you feel?" on a 5-point scale (1 = not at all, 5 = extremely) via button response. The order of blocks was pseudo-randomized over 4 separate runs of 5 min each. Consistent with prior studies involving healthy participants ([@bb0450], [@bb0455]) and anxious individuals who did not receive CBT ([@bb0460], [@bb0465], [@bb0470], [@bb0475]), all conditions were practiced with images not used in the experiment prior to the scan to ensure understanding of task instructions.

2.5. fMRI data acquisition and preprocessing {#s0035}
--------------------------------------------

Scanning was conducted on a 3.0 Tesla MR 750 scanner (General Electric Healthcare; Waukesha, WI) using a standard radiofrequency coil. Blood oxygen-level dependent (BOLD)-functional images were acquired using a gradient-echo echo-planar imaging sequence with the following parameters: TR = 2 s, TE = 25 ms, flip angle = 90^0^, field of view = 22 × 22 cm ([@bb0010]), acquisition matrix 64 × 64; 44 axial, 3-mm-thick slices with no gap. For anatomical localization, a high-resolution, T1-weighted volumetric anatomical scan was acquired.

Data from all participants met criteria for quality with minimal motion correction (movements were \< 3 mm and \< 3 degrees rotation in any one direction) and the first 4 volumes from each run were discarded to allow for T1 equilibration effects. Conventional preprocessing steps were used in Statistical Parametric Mapping (SPM8) software package (Wellcome Trust Centre for Neuroimaging, London [www.fil.ion.ucl.ac.uk/spm](http://www.fil.ion.ucl.ac.uk/spm){#ir0005}). Briefly, images were temporally corrected to account for differences in slice time collection, spatially realigned to the first image of the first run, normalized to a Montreal Neurological Institute (MNI) template, resampled to 2 × 2 × 2 mm voxels, and smoothed with an 8 mm isotropic Gaussian kernel.

2.6. fMRI analyses {#s0040}
------------------

A general linear model was applied to the time series, convolved with the canonical hemodynamic response function and with a 128 s high-pass filter. Nuisance regressors comprising 6 motion parameters were included to correct for motion artifacts. In EFIT, blocks of low and high perceptual load were modeled separately based on task-irrelevant face type (fearful, angry, neutral) resulting in six regressors (fearful low, fearful high, angry low, angry high, neutral low, neutral high). To maximize threat distractor signal, we collapsed across angry and fear. Threat (fearful, angry) Low vs. Threat (fearful, angry) High load was the contrast of interest as both conditions comprised negative distractors. A Neutral Low vs. Neutral High contrast was also analyzed to determine whether significant effects were driven by task-irrelevant threat as opposed to task-irrelevant neutral distractors.

In ERT, blocks of Reappraise, Maintain, and Look trials were modeled separately in relation to an implicit baseline (i.e., fixation cross), the effects of which were estimated for each voxel. Reappraise vs. Maintain was the contrast of interest as both conditions comprised negative stimuli. Although the design did not involve the reappraisal of neutral images, as is conventional ([@bb0450], [@bb0455], [@bb0460], [@bb0465], [@bb0470], [@bb0475]), the contrast Look vs. Fixation was also analyzed to assess whether activity related to neutral images predicted CBT response.

To test hypothesis, the Automatic Anatomical Labeling (AAL) system ([@bb0480]) was used to generate masks. Rostral ACC (rACC) comprised anterior cingulum encompassing primarily BA24 (search volume = 21,704 mm). AAL median cingulate anterior to y = 0 delineated dorsal ACC (dACC) primarily incorporating BA32 (search volume = 9416 mm) ([Fig. 1](#f0005){ref-type="fig"}). AAL bilateral amygdala had a search volume of 3744 mm ([Fig. 1](#f0005){ref-type="fig"}). Activation (β weights, arbitrary units \[a.u.\]) derived from these regions of interest (ROIs) were submitted to tests in the Statistical Package for the Social Sciences (Chicago, IL version 22).Fig. 1Blue depicts dorsal anterior cingulate cortex mask and green illustrates rostral anterior cingulate cortex mask (left panel). Red represents bilateral amygdala mask (right panel). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 1

Two-tailed Pearson\'s correlations were used to assess associations among rACC, dACC, and amygdala activity during implicit and explicit regulation. ROC curves were used to examine whether these ROIs and non-fMRI continuous measures (e.g., social anxiety symptoms) classified responder status (yes/no). To evaluate stability, significant predictors based on ROC analysis were submitted to binomial logistic regression and bootstrap confidence intervals (10,000 samples) estimated prediction error. To assess relationships between activation and change in symptom severity as indexed with LSAS (Δ~PreTx\ -\ PostTx~), ROIs were submitted to two-tailed partial correlations with alpha level at 0.05 controlling for baseline symptom severity.

3. Results {#s0045}
==========

3.1. Participants {#s0050}
-----------------

Thirty-eight patients with SAD (63% female) had a mean age of 25.2 ± 5.9 years and education level of 15.7 ± 2.6 years. Average symptom severity (LSAS total score) was 77.8 ± 15.8, which is consistent with the generalized SAD subtype ([@bb0485]). The HAM-D total score indicated patients were mildly symptomatic (average 8.0 ± 5.2) ([@bb0490]).

With regard to comorbidity, 12 patients had generalized anxiety disorder; 9, major depressive disorder; 7, dysthymia; 3, specific phobia; 3, panic disorder; 2, posttraumatic stress disorder; 1, adjustment disorder; 1, alcohol abuse; and 1, an eating disorder. Twelve patients had two or more comorbid diagnoses. Concerning race/ethnicity 53% self-identified as Caucasian, 18% as Asian, 8% as African American, 3% as American Indian or Alaskan Native, 18% as more than one race, and 42% self-identified as Hispanic or Latino.

3.2. Treatment effects {#s0055}
----------------------

After completing 12 sessions of CBT, all patients showed significant pre-to-post treatment reductions in social anxiety symptoms (LSAS \[(37) *t* = 8.78, *p* \< 0.001\]) and depression level (HAM-D \[t(37) = 5.67, *p* \< 0.001\]). Self-report revealed a pre-to-post CBT increase in attentional control (ACS \[t(37) = 4.46, *p* \< 0.001\]). Regarding emotion regulation tendencies, post-CBT data was missing for one subject. Nevertheless, ERQ results showed a pre-to-post increase in the habitual use of reappraisal (ERQ \[t(36) = 6.65, *p* \< 0.001\]) and a decrease in the less adaptive regulation strategy, suppression ([@bb0175]) (ERQ \[t(36) = 2.18, *p* \< 0.036\]). See [Table 1](#t0005){ref-type="table"} for descriptive statistics.Table 1Descriptive statistics (M, mean; SD, standard deviation) for clinical and emotion regulation measures.Table 1Pre-CBT\
*M (SD)*Post-CBT\
*M (SD)p*Cohen\'s *d*LSAS77.8 (15.8)49.2 (25.5)\< 0.0011.6HAM-D8.0 (5.2)3.5 (3.6)\< 0.0011.0ACS46.5 (8.5)52.0 (9.2)\< 0.001-0.7ERQ-R23.4 (5.8)29.6 (5.2)\< 0.001-1.1ERQ-S17.3 (5.9)15.4 (6.0)0.0360.6[^1]

As determined with CGI and RCI comprising LSAS, 34.2% (13/38) were considered CBT Responders and 65.8% (25/38) were Non-Responders. Responders and Non-Responders were equivalent in pre-CBT symptom severity (LSAS \[t(36) = 1.34, *p* = 0.19\]), depression level (HAM-D \[t(36) = 1.39, *p* = 0.17\]), attentional control (ACS \[t(36) = 0.05, *p* = 0.96\]), use of reappraisal \[t ([@bb0180])=0.19, *p* = 0.85\] and suppression \[t ([@bb0180])=1.01, *p* = 0.32\] (ERQ), age \[t ([@bb0180])=1.62, *p* = 0.12\], education level in years \[t ([@bb0180])=0.76, *p* = 0.45\], and race/ethnicity \[*χ*^*2*^ *(*[@bb0020]*)*=5.85, *p* = 0.21\].

3.3. Implicit emotion regulation behavioral performance {#s0060}
-------------------------------------------------------

To assess the effectiveness of task conditions, accuracy and reaction time (RT) for accurate trials were submitted to a 2 (Distractor type: threat, neutral) × 2 (Perceptual Load: low, high) ANOVA with repeated measures on the last factor. Results for accuracy revealed a main effect of Load \[F ([@bb0005], [@bb0185]) = 323.40, *p* \< 0.001\] but not Distractor type \[F ([@bb0005], [@bb0185]) = 2.19, *p* = 0.15\]; there was no Load × Distractor interaction \[F ([@bb0005], [@bb0185]) = 0.59, *p* = 0.45\]. Follow-up paired *t*-tests showed all participants were more accurate on average in identifying targets in the low (95% ± 7%) relative to high load (63% ± 11%) condition \[t ([@bb0185]) = 18.09, *p* \< 0.001\]. RT findings were similar as there was a main effect of Load \[F ([@bb0005], [@bb0185])=358.53, *p* \< 0.001\] but not Distractor \[F ([@bb0005], [@bb0185]) = 0.79, *p* = 0.79\] and there was no interaction \[F ([@bb0005], [@bb0185]) = 0.51, *p* = 0.48\]. Follow-up paired *t*-tests showed all participants were faster on average in identifying targets in the low (817.27 ms ± 121.70 ms) compared to high load (1172.31 ms ± 182.11 ms) condition \[t ([@bb0185]) = 18.94, *p* \< 0.001\].

3.4. Explicit emotion regulation behavioral performance {#s0065}
-------------------------------------------------------

As a manipulation check, a repeated measures ANOVA for Reappraise, Maintain, and Look revealed a main effect of condition \[F ([@bb0010], [@bb0370]) = 128.04, *p* \< 0.001\]. Follow-up paired *t*-tests demonstrated patients reported feeling less negative during Reappraise (2.53 ± 0.80) than Maintain (2.98 ± 0.58) (t(37) = 4.21, *p* \< 0.001). As expected, negative affective state was higher in Maintain relative to Look (1.34 ± 0.51) (t(37) = 16.67, *p* \< 0.001) and Reappraise relative to Look (t(37) = 10.64, *p* \< 0.001).

3.5. Predictors of responder status {#s0070}
-----------------------------------

ROC curve analysis indicated clinically-meaningful change was not predicted by baseline symptom severity (i.e., LSAS, HAM-D), demographic characteristics (age, education level), self-reported attentional control (ACS), emotion regulation tendencies (ERQ), or race/ethnicity (as tested with chi square); lowest *p* = 0.08.

### 3.5.1. Implicit regulation {#s0075}

To assess regulatory facility at the neural level, Pearson\'s correlations for threat distractors in the Low (\> High) load condition were conducted. Results showed amygdala activity positively correlated with rACC (*r* = 0.44, *p* \< 0.01) and dACC (*r* = 0.46, *p* \< 0.04). To evaluate the predictive ability of ROIs, ROC curve analysis was performed. Findings revealed responder status was predicted by greater baseline EFIT activity (larger result indicates more positive test) in the rACC for threat distractors in Low (\> High) load condition (Area = 0.74, *p* \< 0.02) as well as amygdala (Area = 0.75, *p* \< 0.01) ([Fig. 2](#f0010){ref-type="fig"}). Results were not significant for dACC (Area = 0.64, *p* = 0.17). To estimate prediction error, rACC and amygdala were each submitted to separate binomial linear regression analysis where predictor criterion (yes/no based on CGI and RCI for LSAS) was the dependent variable. Bootstrap results for rACC was B = 0.33, SE = 0.20 (CI 95%: 0.10 to 0.83) and for amygdala, B = 0.47, SE = 0.25 (CI 95%: 0.17 to 1.14).Fig. 2ROC curves for implicit regulation; green depicts rostral anterior cingulate cortex and red illustrates amygdala (left panel). ROC curve regarding explicit regulation; green represents rostral anterior cingulate cortex (right panel). ROC, Receiver operating characteristic.Fig. 2

Concerning neutral distractors in Low (\> High) perceptual load, Pearson\'s correlations showed amygdala activity was negatively associated with dACC (*r* = − 0.32, *p* \< 0.05) but not rACC (*r* = − 0.24, *p* = 0.15). ROC curve results were not significant for rACC, dACC, or amygdala (lowest *p* = 0.16).

### 3.5.2. Explicit regulation {#s0080}

In Reappraise (\> Maintain), amygdala positively correlated with rACC (*r* = 0.50, *p* \< 0.001) and dACC (*r* = 0.53, *p* \< 0.001). ROC curve analysis revealed less (smaller result indicates more positive test) baseline rACC activation in Reappraise (\> vs. Maintain) differentiated responders from non-responders (Area = 0.72, *p* \< 0.03) ([Fig. 2](#f0010){ref-type="fig"}). Findings were not significant for dACC (Area = 0.57, *p* = 0.51) or amygdala activity (Area = 0.60, *p* = 0.30). Bootstrap results for rACC was B = − 1.74, SE = 0.84 (CI 95%: -3.9 to − 0.68). Regarding Look (\> fixation cross) amygdala activity did not correlate with rACC (*r* = − 0.20, *p* = 0.22) or dACC (*r* = − 0.19, *p* = 0.23). ROC analysis for Look (\> fixation cross) did not reveal significant effects for any region (lowest *p* = 0.57).

3.6. Neurofunctional activity and symptom change {#s0085}
------------------------------------------------

*Implicit regulation:* Partial correlations controlling for baseline symptom severity indexed with LSAS revealed positive relationships between symptom change (Δ~PreTx\ -\ PostTx~) and pre-treatment activity to threat distractors in Low (\> High) perceptual load in rACC (*r* = 0.35, *p* \< 0.033) and amygdala (*r* = 0.48, *p* \< 0.003) ROIs ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Controlling for baseline symptom severity, scatterplots illustrating relationship between pre-to-post CBT change in symptom severity as indexed with LSAS (Liebowitz Social Anxiety Scale) and rostral anterior cingulate activity (left panel) and amygdala activity (right panel) during implicit regulation. Implicit regulation refers to threat distractors under low perceptual load (\> threat distractors under high perceptual load).Fig. 3

No significant relationship between dACC activity and symptom change was observed (*r* = 0.29, *p* = 0.08). Correlations were not significant for neutral distractors in Low (\> High) perceptual load for any region (lowest *p* = 0.55).

*Explicit regulation:* No relationships emerged between symptom change (Δ~PreTx\ -\ PostTx~) and activity in Reappraise (\> Maintain) for rACC (*r* = − 0.29, *p* = 0.08), dACC (*r* = − 0.18, *p* = 0.28), or amygdala (*r* = − 0.11, *p* = 0.53) ROIs when controlling for baseline symptom severity. Correlational analysis for Look (\> fixation cross) were not significant for any region (lowest *p* = 0.24).

4. Discussion {#s0090}
=============

The primary objective of the current study was to test the hypothesis that clinically-meaningful change immediately following CBT would be predicted by baseline anterior cingulate cortex (ACC) activity during emotion regulation in patients with social anxiety disorder (SAD). Amygdala as a CBT neuromarker was an exploratory aim. Behavioral data confirmed patients followed task instructions. For implicit regulation, accuracy was higher and response times faster for threat and neutral distractors in the low, relative to high, perceptual load condition. Moreover, negative affective state was reported as diminished during cognitive reappraisal of negative images compared to experiencing naturally the emotions incurred by such images (i.e., 'Maintain' condition). Yet, despite behavioral evidence of successful implicit and explicit regulation, ACC and amygdala activity, in the presence of negative stimuli, were positively correlated.

Building on models of effective emotion regulation wherein frontal engagement downregulates emotional reactivity (e.g., attenuates amygdala reactivity) ([@bb0285], [@bb0290], [@bb0295], [@bb0300]) along with reports of inefficient or impoverished ACC activity during regulation in SAD ([@bb0315], [@bb0330], [@bb0385]), the absence of pre-CBT inverse ACC-amygdala relationships to threat signals during regulation suggests patients were not effectual or efficient in modulating amygdala response. Even so, our study did not comprise a healthy control comparison group or direct fear processing condition, therefore, we cannot rule out the possibility that the ACC-amygdala relationship constituted emotional reactivity, as opposed to aberrant regulation, as SAD is also associated with exaggerated rACC and dACC response to negative stimuli ([@bb0495]).

With regard to treatment outcome, results revealed social anxiety symptoms significantly decreased after CBT (LSAS Δ~PreTx\ -\ PostTx~); however, many remained symptomatic according to LSAS cut-offs ([@bb0485]). Clinically-meaningful change was observed in approximately 34% of patients, which is consistent with the literature ([@bb0050]). As hypothesized brain activity, but not clinical or demographic measures, significantly classified responder status. Findings are in keeping with accumulating reports that neural predictors are frequently better than clinical or demographic characteristics in determining who is likely to benefit from CBT ([@bb0055], [@bb0060], [@bb0065], [@bb0070]).

Regarding predictor effects, ROC results concerning implicit regulation revealed clinically-meaningful change was foretold by more pre-CBT activity in the rostral ACC (rACC) and amygdala to threat distractors. Findings suggest CBT may be especially helpful for those SAD patients who have relatively less implicit emotion regulation capability at the neural level. Notably, rACC and amygdala engagement were modulated by load on attentional resources such that baseline activation was greater under low (\> high) perceptual load. We propose the rACC and amygdala activity reflected reactivity to task-irrelevant threat signals as demands on cognitive resources were minimal under low load and thus available (i.e., 'left over') to process salient, task-irrelevant stimuli ([@bb0500], [@bb0505]). In other words, activation reflected biased attention to motivationally-relevant signals. Alternatively, rACC and amygdala activity served a preparatory function in resolving emotional conflict ([@bb0320]). Emotion has been shown to expedite conflict resolution, therefore, rACC and amygdala activity may pertain to early engagement of a system to effectively carry out an action ([@bb0320], [@bb0510]). However, since the cognitive goal was non-affective in nature (i.e., decide whether an X or N was present) and attentional bias to threat stimuli is frequently reported in SAD ([@bb0190]), rACC and amygdala results suggest relatively poorer regulation facility predicted CBT response.

Concerning explicit regulation, ROC results demonstrated less baseline rACC activity during reappraisal (vs. viewing negative images) significantly predicted responder status yet amygdala did not portend CBT response. Despite the difference in the direction of rACC activation, findings are similar to that of implicit regulation as patients with more deficient regulation did better in CBT. Based on meta-analytic studies involving healthy individuals we expected dACC, not rACC, to correspond with clinical improvement given consistent reports of dACC recruitment in reappraisal ([@bb0305], [@bb0310]). Potentially, CBT neuromarkers are not necessarily linked to functional activity in regions associated with optimal functioning as observed in healthy individuals. Alternatively, our rACC finding maps on to indications rACC is involved in mediating dorsal medial and lateral prefrontal areas associated with reappraisal. For example, in a study that demarcated mediators of reappraisal with a pathway-mapping approach, rACC was shown to be part of a large-scale network that predicted reappraisal success in healthy participants ([@bb0250]).

Implicit and explicit regulation results partially replicate our earlier studies where better CBT outcome in SAD was predicted by less regulation facility in the presence of negative stimuli ([@bb0060], [@bb0350]). However, in these studies neither rACC nor amygdala served as 'CBT neuromarkers.' The inconsistency may be explained by taking a conventional whole-brain approach in previous studies to identify potential neuromarkers rather than the a priori approach employed here such that results are independent of a brain map. In the current study, findings suggest rACC, but not dACC, as a CBT neuromarker pertains to both implicit/automatic and explicit/deliberate forms of regulation in SAD. Findings contribute to early ([@bb0130]) and continued reports of rACC as a biomarker of treatment outcome. That is, neuroimaging and neurophysiological studies comprising tasks that probe affective circuitry, executive functions, or self-referential processes (e.g., resting state) demonstrate elevated baseline rACC activity frequently classifies responder status or corresponds with change in depression severity following various interventions (e.g., pharmacotherapy, neurostimulation, CBT) ([@bb0080], [@bb0085], [@bb0090], [@bb0115]). These data along with evidence of reduced rACC volume in major depressive disorder, SAD, and other anxiety disorders relative to healthy individuals ([@bb0515]) suggests rACC plays a role in the neurobiology of internalizing disorders and may serve as a transdiagnostic marker of clinical outcome.

While the direction of baseline rACC activity (less vs. more) as a predictor was task dependent, results indicate CBT may be particularly helpful to patients who have greater regulation deficiency or inefficiency when using a cognitive approach to downregulate emotional reactivity or when carrying out a cognitive goal in the face of negative distractors. CBT constitutes an amalgam of techniques aimed at decreasing maladaptive thoughts and behaviors while increasing adaptive ones. For example, the reappraise condition is similar to cognitive approaches practiced in CBT (e.g., cognitive restructuring) and commonly used to make social situations less fearful ([@bb0425]).

With regard to attentional control, self-report results revealed a significant increase after completing CBT in SAD. The finding is consistent with evidence CBT success in SAD is associated with enhanced attentional control ([@bb0195], [@bb0200], [@bb0205]). Since CBT does not directly target implicit regulation, the improvement may be due to contingency learning over the course of treatment, which is fostered by activation of a fear structure ([@bb0520]). For example, CBT strategies are practiced in the context of anxiety-evoking events (negative thoughts, in vivo exposures), thus, patients with less attentional control at the start of CBT and, therefore, greater attentional bias to threat stimuli, may be more proficient in learning new contingencies that result from facing fears (i.e., associating a threat signal with a benign outcome). In support, a dot-probe study demonstrated improvement in social anxiety was predicted by attentional bias (i.e., 'vigilance') to threatening faces prior to CBT but not attentional avoidance ([@bb0525]).

Findings also have implications for interventions that more directly target regulation processes. For example, attention bias modification, aimed at directing attention away from threat stimuli, has been shown to reduce attentional bias and anxiety symptoms ([@bb0530], [@bb0535]). Similarly, there is evidence cognitive bias modification, which is intended to reduce negative appraisals, decreases threat interpretation bias and anxiety symptoms ([@bb0540], [@bb0545]). Accordingly, patients with neuromarkers indicative of deficient regulation may benefit more from such targeted treatments alone or as an adjunct to CBT.

A secondary aim of the current study was to evaluate relationships between pre-CBT neurofunctional activity and pre-to-post change in symptom severity (LSAS Δ~PreTx\ -\ PostTx~). Partial correlations controlling for baseline symptom severity revealed rACC and amygdala activation to threat distractors in Low (\> High) perceptual load positively corresponded with change in symptom severity. For explicit regulation, neither the ACC nor amygdala correlated with pre-to-post change in social anxiety symptoms. These data suggest variance related to emotional interference contributed more to individual differences in clinical improvement than explicit regulation insofar as ACC and amygdala are concerned. It is possible that providing instructions on cognitive regulation strategies along with the practice of reappraisal to ensure understanding of instructions before the experiment may have reduced individual differences at the neural level.

This study is not without important limitations. First and foremost, there was no treatment control or waitlist control group, therefore, neural and clinical findings cannot be causally attributed to CBT and could be due to factors not related to treatment such as differential regression to the mean, response biases, Hawthorne effect, other non-specific factors, or natural recovery in patients. Second, our sample size was relatively modest and not adequately powered to evaluate the stability of neural predictors beyond bootstrapping. Third, regions of interest (ROIs) were based on an atlas and, therefore, may not be as accurate as manually-traced ROIs. Fourth, we used a recommended approach to define responder status ([@bb0430]), which may be considered overly conservative. Fifth, implicit emotion regulation comprised threatening face distractors and explicit regulation consisted of generally negative images. Therefore, the potential influence of stimuli on results cannot be ruled out and findings may not generalize to other types of negative content (e.g., ideographic stimuli). Sixth, the objective of the study was to test a priori regions of interest as predictors outside a brain map; consequently, no conclusions can be made with regard to its significance at the whole-brain level. Lastly, CBT encompasses an amalgam of techniques; therefore, we cannot conclude neural predictors are limited to any one particular cognitive or behavioral strategy.

In summary, the ACC has consistently been implicated as a neuromarker in treatment response albeit in depression. The ACC is theoretically-relevant to CBT due to the role it plays in emotion regulation, which CBT aims to improve. The predictive validity of amygdala was also evaluated due to its strong connectivity with ACC ([@bb0395]). In SAD patients, results revealed greater baseline rostral ACC and amygdala reactivity during implicit regulation was predictive of clinically-meaningful improvement. Additionally, activation in these regions were associated with reductions in social anxiety symptoms. For explicit regulation, improvement corresponded with less baseline rostral ACC activity in cognitive reappraisal. However, neither ACC nor amygdala activity in the context of reappraisal corresponded with change in symptom severity. Together, these preliminary data are in line with early observations that rostral ACC recurrently interacts with treatment outcome. Further study with larger samples are needed to test the stability and generalizability of rostral ACC as a predictor in CBT response.
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[^1]: LSAS = Liebowitz Social Anxiety Scale; HAM-D = Hamilton Depression Rating Scale; ACS = Attention Control Scale; ERQ-R = Emotion Regulation Questionnaire, Reappraisal Subscale; ERQ-S = Emotion Regulation Questionnaire, Suppression Subscale.
